{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T10:58:35Z","timestamp":1753181915278},"reference-count":21,"publisher":"Elsevier BV","issue":"3","content-domain":{"domain":["gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.ygyno.2013.09.016","type":"journal-article","created":{"date-parts":[[2013,9,21]],"date-time":"2013-09-21T01:07:20Z","timestamp":1379725640000},"page":"561-566","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["The role of surgery in the management of patients with platinum-sensitive recurrent ovarian cancer: Survey among Dutch gynecologists and medical oncologists"],"prefix":"10.1016","volume":"131","clinical-trial-number":[{"clinical-trial-number":"nct00565851","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01166737","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"ntr3337","registry":"10.18810\/dutch-trial-register"}],"author":[{"given":"Rafli","family":"van de Laar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra L.M.","family":"Zusterzeel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toon","family":"Van Gorp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petronella B.","family":"Ottevanger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leon F.A.G.","family":"Massuger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roy F.P.M.","family":"Kruitwagen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2013.09.016_bb0005","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1016\/S0959-8049(11)70154-X","article-title":"Clinical trials and decision-making strategies for optimal treatment of relapsed ovarian cancer","volume":"47","author":"Ledermann","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ygyno.2013.09.016_bb0010","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1016\/S0140-6736(03)13718-X","article-title":"Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4\/AGO-OVAR-2.2 trial","volume":"361","author":"Parmar","year":"2003","journal-title":"Lancet"},{"issue":"Suppl. 1","key":"10.1016\/j.ygyno.2013.09.016_bb0015","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1525-1438.2005.15355.x","article-title":"Combination therapy with gemcitabine and carboplatin in recurrent ovarian cancer","volume":"15","author":"Pfisterer","year":"2005","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2013.09.016_bb0020","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1200\/JCO.2012.42.0505","article-title":"OCEANS: a randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer","volume":"30","author":"Aghajanian","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2013.09.016_bb0025","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ygyno.2008.08.033","article-title":"Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis","volume":"112","author":"Bristow","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.09.016_bb0030","first-page":"CD007822","article-title":"Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer","author":"Galaal","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ygyno.2013.09.016_bb0035","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/IGC.0b013e31821bb8aa","article-title":"Clinical trials in recurrent ovarian cancer","volume":"21","author":"Friedlander","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2013.09.016_bb0040","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.2196\/jmir.6.3.e34","article-title":"Improving the quality of Web surveys: the Checklist for Reporting Results of Internet E-Surveys (CHERRIES)","volume":"6","author":"Eysenbach","year":"2004","journal-title":"J Med Internet Res"},{"key":"10.1016\/j.ygyno.2013.09.016_bb0045","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1245\/s10434-006-9058-0","article-title":"Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial","volume":"13","author":"Harter","year":"2006","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.ygyno.2013.09.016_bb0050","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.ygyno.2013.05.040","article-title":"Survival impact of complete cytoreduction to no gross residual disease for advanced-stage ovarian cancer: a meta-analysis","volume":"130","author":"Chang","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.09.016_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/613980","article-title":"The role of secondary surgery in recurrent ovarian cancer","volume":"2012","author":"Lorusso","year":"2012","journal-title":"Int. J. Surg. Oncol."},{"key":"10.1016\/j.ygyno.2013.09.016_bb0060","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/IGC.0b013e31820aaafd","article-title":"Prospective validation study of a predictive score for operability of recurrent ovarian cancer: the Multicenter Intergroup Study DESKTOP II. A project of the AGO Kommission OVAR, AGO Study Group, NOGGO, AGO-Austria, and MITO","volume":"21","author":"Harter","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2013.09.016_bb0065","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1245\/s10434-011-1873-2","article-title":"A risk model for secondary cytoreductive surgery in recurrent ovarian cancer: an evidence-based proposal for patient selection","volume":"19","author":"Tian","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ygyno.2013.09.016_bb0070","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ejogrb.2008.05.006","article-title":"Predictive value of PET-CT imaging versus AGO-scoring in patients planned for cytoreductive surgery in recurrent ovarian cancer","volume":"140","author":"Lenhard","year":"2008","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ygyno.2013.09.016_bb0075","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1245\/s10434-006-9273-8","article-title":"Secondary cytoreductive surgery in patients with platinum-sensitive recurrent ovarian cancer","volume":"14","author":"Benedetti Panici","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ygyno.2013.09.016_bb0080","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1471-2407-12-31","article-title":"Laparoscopy to predict the result of primary cytoreductive surgery in advanced ovarian cancer patients (LapOvCa-trial): a multicentre randomized controlled study","volume":"12","author":"Rutten","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ygyno.2013.09.016_bb0085","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ejso.2010.04.012","article-title":"Perioperative morbidity and outcome of secondary cytoreduction for recurrent epithelial ovarian cancer","volume":"36","author":"Woelber","year":"2010","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ygyno.2013.09.016_bb0090","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ygyno.2008.11.011","article-title":"Specialized and high-volume care leads to better outcomes of ovarian cancer treatment in the Netherlands","volume":"112","author":"Vernooij","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.09.016_bb0095","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ygyno.2010.05.025","article-title":"The National Cancer Database report on advanced-stage epithelial ovarian cancer: impact of hospital surgical case volume on overall survival and surgical treatment paradigm","volume":"118","author":"Bristow","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.09.016_bb0100","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ygyno.2010.01.014","article-title":"Surveillance for the detection of recurrent ovarian cancer: survival impact or lead-time bias?","volume":"117","author":"Tanner","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.09.016_bb0105","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/IGC.0b013e3182261f15","article-title":"ESGO statement on the role of CA-125 measurement in follow-up of epithelial ovarian cancer","volume":"22","author":"van der Zee","year":"2012","journal-title":"Int J Gynecol Cancer"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825813011906?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825813011906?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T16:24:19Z","timestamp":1539361459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825813011906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0090825813011906"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2013.09.016","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of surgery in the management of patients with platinum-sensitive recurrent ovarian cancer: Survey among Dutch gynecologists and medical oncologists","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2013.09.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}